Amicus Therapeutics Stock Price Prediction
| FOLD Stock | USD 10.66 0.02 0.19% |
Oversold Vs Overbought
37
Oversold | Overbought |
Amicus Therapeutics stock price prediction is an act of determining the future value of Amicus Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Amicus Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Amicus Therapeutics and does not consider all of the tangible or intangible factors available from Amicus Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Amicus Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Amicus Therapeutics' stock price prediction:EPS Estimate Next Quarter (0.05) | EPS Estimate Next Year 0.39 | Wall Street Target Price 18.75 | EPS Estimate Current Quarter (0.06) | Quarterly Revenue Growth 0.306 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Amicus Therapeutics based on different types of headlines from major news networks to social media. The Amicus stock price prediction module provides an analysis of price elasticity to changes in media outlook on Amicus Therapeutics over a specific investment horizon. Using Amicus Therapeutics hype-based prediction, you can estimate the value of Amicus Therapeutics from the perspective of Amicus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Amicus Therapeutics using Amicus Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Amicus using crowd psychology based on the activity and movement of Amicus Therapeutics' stock price.
Amicus Therapeutics Short Interest
A significant increase or decrease in Amicus Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Amicus. Short interest can provide insight into the potential direction of Amicus Therapeutics stock and how bullish or bearish investors feel about the market overall. An investor who is long Amicus Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Amicus Therapeutics and may potentially protect profits, hedge Amicus Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 12.2904 | Short Percent 0.1105 | Short Ratio 9.84 | Shares Short Prior Month 32.4 M | 50 Day MA 12.3848 |
Amicus Therapeutics Hype to Price Pattern
Investor biases related to Amicus Therapeutics' public news can be used to forecast risks associated with an investment in Amicus. The trend in average sentiment can be used to explain how an investor holding Amicus can time the market purely based on public headlines and social activities around Amicus Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Amicus Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Amicus Therapeutics.
Amicus Therapeutics Implied Volatility | 77.36 |
Amicus Therapeutics' implied volatility exposes the market's sentiment of Amicus Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amicus Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amicus Therapeutics stock will not fluctuate a lot when Amicus Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Amicus Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Amicus Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Amicus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Amicus Therapeutics after-hype prediction price | USD 10.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Amicus contract
Based on the Rule 16, the options market is currently suggesting that Amicus Therapeutics will have an average daily up or down price movement of about 4.84% per day over the life of the 2024-04-19 option contract. With Amicus Therapeutics trading at USD 10.66, that is roughly USD 0.52 . If you think that the market is fully incorporating Amicus Therapeutics' daily price movement you should consider acquiring Amicus Therapeutics options at the current volatility level of 77.36%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Amicus |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Amicus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Amicus Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Amicus Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amicus Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Amicus Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amicus Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Amicus Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amicus Therapeutics' historical news coverage. Amicus Therapeutics' after-hype downside and upside margins for the prediction period are 8.00 and 13.14, respectively. We have considered Amicus Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amicus Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Amicus Therapeutics is based on 3 months time horizon.
Amicus Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Amicus Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amicus Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amicus Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.27 | 2.58 | 0.01 | 0.03 | 14 Events / Month | 17 Events / Month | In about 14 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
10.66 | 10.57 | 0.84 |
|
Amicus Therapeutics Hype Timeline
Amicus Therapeutics is currently traded for 10.66. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.03. Amicus is expected to decline in value after the next headline, with the price expected to drop to 10.57. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.84%, whereas the daily expected return is currently at -0.27%. The volatility of related hype on Amicus Therapeutics is about 2270.4%, with the expected price after the next announcement by competition of 10.69. About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.51. Amicus Therapeutics last dividend was issued on the 31st of August 2009. Given the investment horizon of 90 days the next expected press release will be in about 14 days. Check out Amicus Therapeutics Basic Forecasting Models to cross-verify your projections.Amicus Therapeutics Related Hype Analysis
Having access to credible news sources related to Amicus Therapeutics' direct competition is more important than ever and may enhance your ability to predict Amicus Therapeutics' future price movements. Getting to know how Amicus Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amicus Therapeutics may potentially react to the hype associated with one of its peers.
Amicus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Amicus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amicus using various technical indicators. When you analyze Amicus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Amicus Therapeutics Predictive Indicators
The successful prediction of Amicus Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Amicus Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Amicus Therapeutics based on analysis of Amicus Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Amicus Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amicus Therapeutics's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.004788 | 0.001221 | 0.001404 | 0.001334 | Price To Sales Ratio | 10.26 | 10.72 | 10.49 | 9.96 |
Story Coverage note for Amicus Therapeutics
The number of cover stories for Amicus Therapeutics depends on current market conditions and Amicus Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Amicus Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Amicus Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Amicus Therapeutics Short Properties
Amicus Therapeutics' future price predictability will typically decrease when Amicus Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Amicus Therapeutics often depends not only on the future outlook of the potential Amicus Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amicus Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 295.2 M | |
| Cash And Short Term Investments | 286.2 M |
Check out Amicus Therapeutics Basic Forecasting Models to cross-verify your projections. For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Amicus Stock analysis
When running Amicus Therapeutics' price analysis, check to measure Amicus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicus Therapeutics is operating at the current time. Most of Amicus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amicus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicus Therapeutics' price. Additionally, you may evaluate how the addition of Amicus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Amicus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amicus Therapeutics. If investors know Amicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amicus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Revenue Per Share 1.353 | Quarterly Revenue Growth 0.306 | Return On Assets (0.06) | Return On Equity (1.07) |
The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amicus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.